|
1
|
Fagin JA and Wells SA Jr: Biologic and
clinical perspectives on thyroid cancer. N Engl J Med.
375:1054–1067. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Appetecchia M, Lauretta R, Barnabei A,
Pieruzzi L, Terrenato I, Cavedon E, Mian C, Castagna MG and Elisei
R; SIE (Italian Society of Endocrinology) Working Group, :
Epidemiology of simultaneous medullary and papillary thyroid
carcinomas (MTC/PTC): An Italian multicenter study. Cancers
(Basel). 11:15162019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wong RL, Kazaure HS, Roman SA and Sosa JA:
Simultaneous medullary and differentiated thyroid cancer: A
population-level analysis of an increasingly common entity. Ann
Surg Oncol. 19:2635–2642. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hales M, Rosenau W, Okerlund MD and
Galante M: Carcinoma of the thyroid with a mixed medullary and
follicular pattern: morphologic, immunohistochemical, and clinical
laboratory studies. Cancer. 50:1352–1359. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim WG, Gong G, Kim EY, Kim TY, Hong SJ,
Kim WB and Shong YK: Concurrent occurrence of medullary thyroid
carcinoma and papillary thyroid carcinoma in the same thyroid
should be considered as coincidental. Clin Endocrinol (Oxf).
72:256–263. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seib CD and Sosa JA: Evolving
understanding of the epidemiology of thyroid cancer. Endocrinol
Metab Clin North Am. 48:23–35. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharbidre KG, Lockhart ME and Tessler FN:
Incidental thyroid nodules on imaging: Relevance and management.
Radiol Clin North Am. 59:525–533. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shetty SK, Maher MM, Hahn PF, Halpern EF
and Aquino SL: Significance of incidental thyroid lesions detected
on CT: Correlation among CT, sonography, and pathology. AJR Am J
Roentgenol. 187:1349–1356. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Poller DN and Glaysher S: Molecular
pathology and thyroid FNA. Cytopathology. 28:475–481. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Biscolla RP, Ugolini C, Sculli M, Bottici
V, Castagna MG, Romei C, Cosci B, Molinaro E, Faviana P, Basolo F,
et al: Medullary and papillary tumors are frequently associated in
the same thyroid gland without evidence of reciprocal influence in
their biologic behavior. Thyroid. 14:946–952. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Costante G and Filetti S: Early diagnosis
of medullary thyroid carcinoma: Is systematic calcitonin screening
appropriate in patients with nodular thyroid disease? Oncologist.
16:49–52. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wells SA Jr, Asa SL, Dralle H, Elisei R,
Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, et al:
Revised American thyroid association guidelines for the management
of medullary thyroid carcinoma. Thyroid. 25:567–610. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Filetti S, Durante C, Hartl D, Leboulleux
S, Locati LD, Newbold K, Papotti MG and Berruti A; ESMO Guidelines
Committee, : Electronic address: simpleClinicalguidelines@esmo.org:
Thyroid cancer: ESMO clinical practice guidelines for diagnosis,
treatment and follow-up†. Ann Oncol. 30:1856–1883. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vance J and Gilani SM: Thyroid
cytopathology: updates and molecular testing. Pathologica.
111:51–57. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gurkan E, Gurbuz Y, Tarkun I, Canturk Z
and Cetinarslan B: Mixed medullary-papillary carcinoma of the
thyroid: report of two cases and review of the literature. Indian J
Pathol Microbiol. 57:598–602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jain M, Verma D, Thomas S and Chauhan R:
Mixed medullary-papillary carcinoma thyroid: An uncommon variant of
thyroid carcinoma. J Lab Physicians. 6:133–135. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nangue C, Bron L, Portmann L, Volante M,
Ris HB, Monnier P and Andrejevic-Blant S: Mixed medullary-papillary
carcinoma of the thyroid: Report of a case and review of the
literature. Head Neck. 31:968–974. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Araque KA, Gubbi S and Klubo-Gwiezdzinska
J: Updates on the management of thyroid cancer. Horm Metab Res.
52:562–577. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim M and Kim BH: Current guidelines for
management of medullary thyroid carcinoma. Endocrinol Metab
(Seoul). 36:514–524. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Viola D and Elisei R: Management of
medullary thyroid cancer. Endocrinol Metab Clin North Am.
48:285–301. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Durante C, Puxeddu E, Ferretti E, Morisi
R, Moretti S, Bruno R, Barbi F, Avenia N, Scipioni A, Verrienti A,
et al: BRAF mutations in papillary thyroid carcinomas inhibit genes
involved in iodine metabolism. J Clin Endocrinol Metab.
92:2840–2843. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu D, Hu S, Hou P, Jiang D, Condouris S
and Xing M: Suppression of BRAF/MEK/MAP kinase pathway restores
expression of iodide-metabolizing genes in thyroid cells expressing
the V600E BRAF mutant. Clin Cancer Res. 13:1341–1349. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stramazzo I, Capriello S, Antonelli A,
Fallahi P, Centanni M and Virili C: Seeking optimization of LT4
treatment in patients with differentiated thyroid cancer. Hormones
(Athens). 21:537–543. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pellegriti G, Leboulleux S, Baudin E,
Bellon N, Scollo C, Travagli JP and Schlumberger M: Long-term
outcome of medullary thyroid carcinoma in patients with normal
postoperative medical imaging. Br J Cancer. 88:1537–1542. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Franc S, Niccoli-Sire P, Cohen R, Bardet
S, Maes B, Murat A, Krivitzky A and Modigliani E; French Medullary
Study Group (GETC), : Complete surgical lymph node resection does
not prevent authentic recurrences of medullary thyroid carcinoma.
Clin Endocrinol (Oxf). 55:403–409. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Giraudet AL, Vanel D, Leboulleux S,
Aupérin A, Dromain C, Chami L, Ny Tovo N, Lumbroso J, Lassau N,
Bonniaud G, et al: Imaging medullary thyroid carcinoma with
persistent elevated calcitonin levels. J Clin Endocrinol Metab.
92:4185–4190. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Machens A, Lorenz K and Dralle H:
Prediction of biochemical cure in patients with medullary thyroid
cancer. Br J Surg. 107:695–704. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Walgama E, Busaidy N and Zafereo M: Novel
therapeutics and treatment strategies for medullary thyroid cancer.
Endocrinol Metab Clin North Am. 51:379–389. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bangaraiahgari R, Panchangam RB,
Puthenveetil P, Mayilvaganan S, Bangaraiahgari R, Banala RR,
Karunakaran P and Md R: Is there adenoma-carcinoma sequence between
benign adenoma and papillary cancer of thyroid: A genomic linkage
study. Ann Med Surg (Lond). 60:695–700. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yoo MH and Hatfield DL: The cancer stem
cell theory: Is it correct? Mol Cells. 26:514–516. 2008.PubMed/NCBI
|
|
31
|
Pishdad R, Cespedes L, Boutin R, Jaloudi M
and Raghuwanshi M: Coexistence of two different thyroid
malignancies: A collision phenomenon. Cureus.
12:e75392020.PubMed/NCBI
|
|
32
|
Ciampi R, Romei C, Pieruzzi L, Tacito A,
Molinaro E, Agate L, Bottici V, Casella F, Ugolini C, Materazzi G,
et al: Classical point mutations of RET, BRAF and RAS oncogenes are
not shared in papillary and medullary thyroid cancer occurring
simultaneously in the same gland. J Endocrinol Invest. 40:55–62.
2017. View Article : Google Scholar : PubMed/NCBI
|
